MBC RESEARCH NEWS Treating BRCA1/2 Metastatic Breast Cancer

JULY 2018

Treating BRCA1/2 Metastatic Breast Cancer

Reading this article from Breastcancer.org along with the FDA’s press release and a viewpoint by cancer writer Elaine Schattner, provides three perspectives and good context for women with BRCA+ metastatic breast cancer wondering if Lynparza is right for them.

Leave a Reply